glp 1 select trial SGLTi and GLP-1 in HF GLP-1 Receptor Agonists as Treatments

Nausea and vomiting are less frequent in patients receiving EX-LAR than in patients taking EX (114)

van der Westhuizen, E

6 In the EXAMINE trial, a safety signal for increased risk of hospitalisation for heart failure was identified with alogliptin, particularly in people with a history of heart failure

P = 0.03), but not placebo (MD = 0.64

American association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update

Some people taking Ozempic report unpleasant mouth odor, but Ozempic breath is a patient-coined term, not an official diagnosis, and it does not occur in everyone